![](/accounts/isop/images/logo.png)
Long Lasting Injectables, Shorter Path to Approval
Includes a Live Web Event on 11/20/2024 at 12:00 PM (EST)
-
You must log in to register
- Member - Free!
Overview of the 2024 MIDD Webinar Series
The 2024 MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.
![Speaker image](https://482ddb490551e34045b1-2722ce6458a1eafa0a49e430ba6315ed.ssl.cf2.rackcdn.com/isop_fba62806f79ef14c7cfce3732e4b87e5.png)
Emma Hughes
Pharmacometrician
Gilead Sciences
Emma received her bachelor’s degree in chemistry from Mount Holyoke College. She went on to join the National Center for Advancing the Translational Science’s DMPK group. There she performed both bioanalysis as well as determined a compound’s preclinical PK profile for small molecules. Emma received her PhD from the University of California San Francisco’s Pharmaceutical Sciences and Pharmacogenomics program where her research focused on building PK/PD models for infectious diseases in special populations, primarily malaria in pregnant women.